Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000665099> ?p ?o ?g. }
- W2000665099 endingPage "1956" @default.
- W2000665099 startingPage "1956" @default.
- W2000665099 abstract "Rheumatoid arthritis (RA) is a complex, multicellular disease involving a delicate balance between both pro- and anti-inflammatory cytokines which ultimately determines the disease phenotype. The simultaneous presence of multiple signaling molecules, and more specifically their relative levels, potentially influences the efficacy of directed therapies. Using the human U937 monocytic cell line, we generated a self-consistent dataset measuring 50 cytokines and 23 phosphoproteins in the presence of 6 small molecule inhibitors under 15 stimulatory conditions throughout a 24 hour time course. From this dataset, we are able to explore phosphoprotein and cytokine relationships, as well as evaluate the significance of cellular context on the ability of small molecule inhibitors to block inflammatory processes. We show that the ability of a p38 inhibitor to attenuate TNFα production is influenced by local levels of GM-CSF and IL-1β, two cytokines known to be elevated in the joints of RA patients. Within the cell, compensatory mechanisms between signaling pathways are apparent, as selective p38 MAPK inhibition results in the increased phosphorylation of other MAPKs (ERK and JNK) and their downstream substrates (CREB, c-Jun, and ATF-2). Further, we demonstrate that TNFα-neutralizing antibodies have secondary effects on cytokine production, impacting more than just TNFα alone. p38 MAPK inhibition using a small molecule inhibitor also blocks production of anti-inflammatory cytokines including IL-10, IL-1ra and IL-2ra. Collectively, the impact of cell context on TNFα production and unintended blockade of anti-inflammatory cytokines may compromise the efficacy of p38 inhibitors in a clinical setting. The effort described in this work evaluates the effect of inhibitors on multiple endpoints (both intra- and extracellular), under a range of biologically relevant conditions, thus providing a unique means for differentiation of compounds and potential opportunity for improved pharmacological manipulation of disease endpoints in RA." @default.
- W2000665099 created "2016-06-24" @default.
- W2000665099 creator A5035474346 @default.
- W2000665099 creator A5044653603 @default.
- W2000665099 creator A5060106170 @default.
- W2000665099 creator A5063426870 @default.
- W2000665099 creator A5066151215 @default.
- W2000665099 creator A5083498750 @default.
- W2000665099 date "2010-01-01" @default.
- W2000665099 modified "2023-10-14" @default.
- W2000665099 title "Elevated GM-CSF and IL-1β levels compromise the ability of p38 MAPK inhibitors to modulate TNFα levels in the human monocytic/macrophage U937 cell line" @default.
- W2000665099 cites W1490165777 @default.
- W2000665099 cites W1499836767 @default.
- W2000665099 cites W1510155660 @default.
- W2000665099 cites W1605085939 @default.
- W2000665099 cites W1670891845 @default.
- W2000665099 cites W1691912414 @default.
- W2000665099 cites W1870510950 @default.
- W2000665099 cites W1965909642 @default.
- W2000665099 cites W1968619512 @default.
- W2000665099 cites W1970516040 @default.
- W2000665099 cites W1972359429 @default.
- W2000665099 cites W1972490124 @default.
- W2000665099 cites W1973232910 @default.
- W2000665099 cites W1976365314 @default.
- W2000665099 cites W1977070803 @default.
- W2000665099 cites W1978981032 @default.
- W2000665099 cites W1985262844 @default.
- W2000665099 cites W1995344305 @default.
- W2000665099 cites W2001215330 @default.
- W2000665099 cites W2004636695 @default.
- W2000665099 cites W2005795527 @default.
- W2000665099 cites W2007252822 @default.
- W2000665099 cites W2007911202 @default.
- W2000665099 cites W2009928292 @default.
- W2000665099 cites W2010810795 @default.
- W2000665099 cites W2011945682 @default.
- W2000665099 cites W2014732115 @default.
- W2000665099 cites W2015215846 @default.
- W2000665099 cites W2015613642 @default.
- W2000665099 cites W2016313989 @default.
- W2000665099 cites W2021659381 @default.
- W2000665099 cites W2027092131 @default.
- W2000665099 cites W2033789194 @default.
- W2000665099 cites W2033872649 @default.
- W2000665099 cites W2034657358 @default.
- W2000665099 cites W2036924431 @default.
- W2000665099 cites W2039424267 @default.
- W2000665099 cites W2041570550 @default.
- W2000665099 cites W2042901969 @default.
- W2000665099 cites W2046710165 @default.
- W2000665099 cites W2050375893 @default.
- W2000665099 cites W2052397527 @default.
- W2000665099 cites W2053440052 @default.
- W2000665099 cites W2058068049 @default.
- W2000665099 cites W2062697678 @default.
- W2000665099 cites W2066314640 @default.
- W2000665099 cites W2070044720 @default.
- W2000665099 cites W2074382353 @default.
- W2000665099 cites W2075472790 @default.
- W2000665099 cites W2084758161 @default.
- W2000665099 cites W2086655427 @default.
- W2000665099 cites W2091419870 @default.
- W2000665099 cites W2093440953 @default.
- W2000665099 cites W2098068460 @default.
- W2000665099 cites W2102486637 @default.
- W2000665099 cites W2102623655 @default.
- W2000665099 cites W2106171259 @default.
- W2000665099 cites W2113394933 @default.
- W2000665099 cites W2117366861 @default.
- W2000665099 cites W2119455089 @default.
- W2000665099 cites W2122000071 @default.
- W2000665099 cites W2122734844 @default.
- W2000665099 cites W2123840402 @default.
- W2000665099 cites W2131882149 @default.
- W2000665099 cites W2132049460 @default.
- W2000665099 cites W2132272495 @default.
- W2000665099 cites W2133764756 @default.
- W2000665099 cites W2135279645 @default.
- W2000665099 cites W2138517852 @default.
- W2000665099 cites W2147648627 @default.
- W2000665099 cites W2148251534 @default.
- W2000665099 cites W2154683570 @default.
- W2000665099 cites W2154986972 @default.
- W2000665099 cites W2155702314 @default.
- W2000665099 cites W2155905959 @default.
- W2000665099 cites W2160566942 @default.
- W2000665099 cites W2161975618 @default.
- W2000665099 doi "https://doi.org/10.1039/c002848g" @default.
- W2000665099 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20617251" @default.
- W2000665099 hasPublicationYear "2010" @default.
- W2000665099 type Work @default.
- W2000665099 sameAs 2000665099 @default.
- W2000665099 citedByCount "8" @default.
- W2000665099 countsByYear W20006650992015 @default.
- W2000665099 countsByYear W20006650992017 @default.
- W2000665099 countsByYear W20006650992022 @default.
- W2000665099 countsByYear W20006650992023 @default.